TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
6.87
+0.40 (6.18%)
Nov 28, 2025, 4:00 PM EST - Market closed
TriSalus Life Sciences Employees
TriSalus Life Sciences had 110 employees as of December 31, 2024. The number of employees decreased by 2 or -1.79% compared to the previous year.
Employees
110
Change (1Y)
-2
Growth (1Y)
-1.79%
Revenue / Employee
$365,518
Profits / Employee
-$643,891
Market Cap
343.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 110 | -2 | -1.79% |
| Dec 31, 2023 | 112 | 37 | 49.33% |
| Dec 31, 2022 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TLSI News
- 12 days ago - TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ - Business Wire
- 17 days ago - TriSalus Life Sciences, Inc. (TLSI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance - Business Wire
- 18 days ago - TriSalus Life Sciences, Inc. (TLSI) Discusses Pressure-Enabled Drug Delivery and Advances in Uterine Fibroid Embolization Transcript - Seeking Alpha
- 19 days ago - TriSalus Life Sciences to Participate in Upcoming Investor Conferences - Business Wire
- 20 days ago - TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025 - Business Wire
- 4 weeks ago - TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call - Business Wire
- 3 months ago - TriSalus Life Sciences to Participate in Upcoming September Investor Conferences - Business Wire